We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+8.25%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$9.63B
AUM Growth
+$514M
Cap. Flow
-$223M
Cap. Flow %
-2.32%
Top 10 Hldgs %
52.93%
Holding
102
New
30
Increased
20
Reduced
19
Closed
21

Top Buys

Rank Stock Value
1
AABA
Altaba Inc
AABA
+$676M
2
BCR
CR Bard Inc.
BCR
+$435M
3
MBLY
Mobileye N.V.
MBLY
+$254M
4
NXPI icon
NXP Semiconductors
NXPI
+$163M
5
HUN icon
Huntsman Corp
HUN
+$134M

Top Sells

Rank Stock Value
1
YHOO
Yahoo Inc
YHOO
+$463M
2
BEAV
B/E Aerospace Inc
BEAV
+$322M
3
MJN
Mead Johnson Nutrition Company
MJN
+$319M
4
WWAV
The WhiteWave Foods Company
WWAV
+$205M
5
LLY icon
Eli Lilly
LLY
+$134M

Sector Composition

Rank Sector Weight
1 Technology 25.12%
2 Communication Services 21.9%
3 Healthcare 12.59%
4 Industrials 5.7%
5 Consumer Discretionary 4.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CTXS
26
DELISTED
Citrix Systems Inc
CTXS
$128M 1.33%
1,606,673
+121,549
+8% +$10.1M
INFO
27
DELISTED
IHS Markit Ltd. Common Shares
INFO
$123M 1.28%
2,790,700
-1,022,902
-27% -$45.6M
CHTR icon
28
Charter Communications
CHTR
$15.7B
$113M 1.17%
334,825
-208,205
-38% -$69.5M
TMH
29
DELISTED
Team Health Holdings Inc
TMH
$105M 1.09%
2,298,900
– –
VEON icon
30
VEON
VEON
$3.58B
$79.9M 0.83%
817,341
+399,964
+96% +$39.4M
ABBV icon
31
AbbVie
ABBV
$454B
$60.5M 0.63%
+835,000
New +$56.1M
BIIB icon
32
Biogen
BIIB
$29.5B
$57.7M 0.6%
+212,500
New +$56.2M
CLVS
33
DELISTED
Clovis Oncology, Inc.
CLVS
$57.1M 0.59%
610,000
+530,000
+663% +$32.4M
AGN
34
DELISTED
Allergan plc
AGN
$55.3M 0.57%
227,500
-420,000
-65% -$98.7M
NORD
35
DELISTED
Nord Anglia Education, Inc.
NORD
$50M 0.52%
+1,535,000
New +$47.8M
PTLA
36
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$48M 0.5%
855,000
+470,000
+122% +$18.8M
HUM icon
37
Humana
HUM
$45.8B
$43M 0.45%
178,500
-20,000
-10% -$4.53M
VRSK icon
38
Verisk Analytics
VRSK
$27.1B
$40.7M 0.42%
+482,827
New +$39.1M
WBMD
39
DELISTED
WebMD Health Corp.
WBMD
$39.8M 0.41%
+679,130
New +$37.8M
ELV icon
40
Elevance Health
ELV
$82.1B
$39.5M 0.41%
+210,000
New +$37.7M
IMMU
41
DELISTED
Immunomedics Inc
IMMU
$37.3M 0.39%
4,227,500
+72,500
+2% +$509K
EXEL icon
42
Exelixis
EXEL
$14B
$37.3M 0.39%
1,515,000
-2,000,000
-57% -$42.3M
CAB
43
DELISTED
Cabela's Inc
CAB
$35.9M 0.37%
+605,000
New +$33.5M
KYNB
44
Kyntra Bio
KYNB
$28.5M
$34.6M 0.36%
42,880
+15,600
+57% +$10.9M
RC
45
Ready Capital
RC
$265M
$34.5M 0.36%
2,324,236
– –
FOLD
46
DELISTED
Amicus Therapeutics
FOLD
$30.2M 0.31%
+3,000,000
New +$24.1M
TRCO
47
DELISTED
TRIBUNE MEDIA COMPANY CLASS A
TRCO
$30M 0.31%
+735,000
New +$28.8M
RYAAY icon
48
Ryanair
RYAAY
$29.9B
$25.7M 0.27%
597,033
+137,745
+30% +$5.46M
MON
49
DELISTED
Monsanto Co
MON
$25.4M 0.26%
+215,000
New +$25.1M
GNCMA
50
DELISTED
GCI Liberty, Inc. Class A-1 Common Stock
GNCMA
$23.4M 0.24%
+638,976
New +$23.1M
1
2
3 4

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q2 2017 Portfolio in Review

As of Q2 2017, Farallon Capital Management held 102 positions worth $9.63B, up 5.6% from $9.11B the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Farallon Capital Management's Q2 2017 filing shows 30 new, 20 increased, 19 reduced and 21 closed positions. Its largest new stake was Altaba Inc: 12,427,457 shares worth $677M. The largest sale was Yahoo Inc, an estimated $463M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 15% a quarter earlier, followed by Communication Services and Healthcare.

  • Farallon Capital Management's largest Q2 2017 buy was Altaba Inc: 12,427,457 shares worth $677M.
  • Farallon Capital Management added most to Mobileye N.V. in Q2 2017, an estimated $254M increase.
  • Farallon Capital Management's biggest Q2 2017 reduction was Allergan plc, cutting an estimated $98.7M.
  • Farallon Capital Management fully exited Yahoo Inc in Q2 2017, selling an estimated $463M.
  • Farallon Capital Management's ten largest holdings make up 53% of its $9.63B portfolio in Q2 2017.
  • Farallon Capital Management opened 30 new positions and closed 21 in Q2 2017.
  • Farallon Capital Management's portfolio value rose 5.6% quarter-over-quarter to $9.63B.

Based on Farallon Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.